Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis
Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2016
Συγγραφείς:
Dimopoulos, Meletios A Roussou, Maria Gavriatopoulou, Maria Psimenou, Erasmia Eleutherakis-Papaiakovou, Evangelos Migkou, Magdalini Matsouka, Charis Mparmparousi, Despoina Gika, Dimitra Kafantari, Eftychia others
